Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19

Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Infect Chemother
Main Authors: Kim, Sun Bean, Kim, Jimin, Huh, Kyungmin, Choi, Won Suk, Kim, Yae-Jean, Joo, Eun-Jeong, Kim, Youn Jeong, Yoon, Young Kyung, Heo, Jung Yeon, Seo, Yu Bin, Jeong, Su Jin, Yu, Su-Yeon, Peck, Kyong Ran, Choi, Miyoung, Yeom, Joon Sup
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Assuntos:
Special Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258293/
https://ncbi.nlm.nih.gov/pubmed/34216134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2021.0304
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados